Alphalyse A/S - CRO in cGMP/non-GMP LC-MS/MS Host Cell Protein (HCP) Analysis Service
Alphalyse A/S has pioneered the use of top-of-the-line mass spectrometry (LC-MS/MS) analysis since 2002. Our scientists have completed over 10,000 protein characterization analyses and more than 700 LC-MS-based residual host cell protein (HCP) projects under GMP and non-GMP. As a CRO, we offer HCP analysis services to support biopharmaceutical R&D and manufacturing of patient-safe products such as therapeutic proteins, vaccines, cell & gene therapies.
Date, time and room information
Monday, May 4, 18:00 - 18:15, room Sydney
Category
Commercial stage company
Title of the presentation
Innovation in HCP Analytics: Accelerating R&D, Process Development and Patient Safety with Mass Spectrometry
Speaker information
| Name | Position | Institution |
|---|---|---|
| Ejvind Mortz | Co Founder & CSO | Alphalyse A/S |
Further information for the sponsor website




